- Research works
- 110 ▲ 333% vs 2013–17
- Citations
- 1.7k 15.2 per fractional work
- Top-10% rate
- 13.9% record average 16.5%
- Open access
- 76% world 28%
Not ranked overall: ViiV Healthcare (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does ViiV Healthcare (United Kingdom) specialise in?
Where its research is concentrated relative to its size: Infectious Diseases takes 59.2× the share of its output that it takes of world research.
- Infectious DiseasesSubfield · 20.7 works59×
- MedicineField · 35.7 works3.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.3×. Every wedge is a field page.
- Immunology and Microbiology 15.3×
- Medicine 3.6×
- Health Professions 1.8×
- Economics, Econometrics and Finance 1.5×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Psychology 0.4×
- Biochemistry, Genetics and Molecular Biology 0.3×
- Neuroscience 0.3×
- Chemistry 0.2×
- Mathematics 0.1×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Environmental Science 0.0×
- Engineering 0.0×
Who are the top researchers at ViiV Healthcare (United Kingdom)?
Ranked on the composite score, Melanie Schroeder and Andrew Clark lead among researchers whose main affiliation is ViiV Healthcare (United Kingdom).
- 1 Melanie Schroeder United Kingdom · #207,852 worldwide 296 citations · 18 works
- 2 Andrew Clark United Kingdom · #1,153,834 worldwide 10 citations · 19 works
Which keywords describe research at ViiV Healthcare (United Kingdom)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Antiretroviral Therapy, HIV Infection, HIV Transmission, Preexposure Prophylaxis, Stigma and Discrimination, Drug Resistance, Integrase Inhibitors and Nucleoside Analogues.
- Unemployment
- Health Outcomes
- Hepatitis C Virus
- Mental Health
- harm reduction
- Social Determinants of Health
- Public Health
- Metabolic Abnormalities
- Aging
- Insulin Resistance
- Cardiovascular Disease
- Antibodies
- Immune Response
- Nucleoside Analogues
- Drug Resistance
- Preexposure Prophylaxis
- HIV Infection
- Antiretroviral Therapy
- HIV Transmission
- Stigma and Discrimination
- Integrase Inhibitors
- HIV
- AIDS
- Vaccine
- Inflammation
- Myocardial Infarction
- Bone Mineral Density
- Epidemiology
- Treatment
- drug use
- Antiviral Therapy
- Liver Disease
- Ribavirin
- Precarious Employment
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Antiretroviral Therapy36▲ 425×5 topics
- HIV Infection17▲ 321×2 topics
- HIV Transmission10▲ 276×2 topics
- Preexposure Prophylaxis10▲ 415×1 topic
- Stigma and Discrimination10▲ 415×1 topic
- Drug Resistance10▲ 71×3 topics
- Integrase Inhibitors10▲ 950×1 topic
- Nucleoside Analogues10▲ 950×1 topic
- HIV10▲ 233×3 topics
- Immune Response9▲ 31×6 topics
- AIDS7▲ 571×1 topic
- Antibodies7▲ 257×1 topic
- Vaccine7▲ 36×3 topics
- Cardiovascular Disease7▲ 12×6 topics
- Inflammation7▲ 6.4×6 topics
- Insulin Resistance7▲ 29×4 topics
- Myocardial Infarction7▲ 57×3 topics
- Aging7▲ 24×1 topic
- Bone Mineral Density7▲ 183×2 topics
- Metabolic Abnormalities7▲ 680×1 topic
- Epidemiology5▲ 2.3×15 topics
- Public Health3▲ 3.4×4 topics
- Treatment2▲ 3.4×5 topics
- Social Determinants of Health2▲ 16×3 topics
- drug use2▲ 130×1 topic
- harm reduction2▲ 130×1 topic
- Antiviral Therapy2▲ 34×3 topics
- Mental Health2▲ 2.2×4 topics
- Liver Disease2▲ 33×2 topics
- Hepatitis C Virus1▲ 72×1 topic
- Ribavirin1▲ 72×1 topic
- Health Outcomes1▲ 8.2×2 topics
- Precarious Employment1▲ 31×1 topic
- Unemployment1▲ 23×1 topic
Which research topics does ViiV Healthcare (United Kingdom) publish most on?
By volume in 2022–2025: HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment and HIV-related health complications and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HIV/AIDS Research and Interventions Infectious Diseases 10 works
- 2 HIV/AIDS drug development and treatment Infectious Diseases 10 works
- 3 HIV Research and Treatment Virology 7 works
- 4 HIV-related health complications and treatments Emergency Medicine 7 works
- 5 HIV, Drug Use, Sexual Risk Epidemiology 2 works
- 6 Hepatitis C virus research Hepatology 1 works
- 7 Employment and Welfare Studies General Health Professions 1 works
- 8 Pneumocystis jirovecii pneumonia detection and treatment Epidemiology 1 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 10 HIV/AIDS Impact and Responses Economics and Econometrics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ViiV Healthcare (United Kingdom)'s research output changed?
Output in 2018–2022 was 333% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in London
- University College London
- Imperial College London
- King's College London
- Queen Mary University of London
- London School of Economics and Political Science
- University of London
- Brunel University of London
- London School of Hygiene & Tropical Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.